Industry Report “Vein Illuminator Market Research Report - Global Forecast till 2025” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement, macro economical and governing factors in the Digital Commerce Platform market.Dominant players:Major players of global vein illuminator industry are Infrared Imaging Systems Inc., VueTek Scientific LLC, Venoscope LLC, Christie Medical Holdings Inc., Near Infrared Imaging Inc., Sharn Anesthesia, TransLite LLC, AccuVein Inc., Aimvein Ltd. and others.Vein illuminator Market OverviewVein finder or vein illuminator is a device designed to locate and map subcutaneous veins using principles of optical physics.Vein illuminator employs a variety of techniques such as ultrasound, infrared light and trans-illumination to produce a distinct image of vein structure.Vein illuminator Market growth is expected to register 28.6% CAGR during the forecast period of 2019 to 2025 and held a market value of USD 60.6 Million in 2018.Segments:To generate a bird’s view, the global vein illuminator market is segmented on the basis of technology, and end users.Technology - trans-illumination, infrared illumination, ultrasound, and others.End user - hospitals, blood donation camps, research and academics, others.DriversThe clinical drivers of vein illuminator market are greater patient satisfaction due to reduced pain, trauma, determining correct vascular position in conditions such as obesity, hairy skin, swollen tissue, hypovolemia etc.The growth of demand factors such as growing numbers of elderly and chronic sick population, blood donation camps, assisted living centers and others are also charging the market.Get Global Vein Illuminator Market Research Report: Information by Technology (Transillumination, Near Infrared Illumination and Ultrasound Technologies), Application (Intravenous Access, Blood Draw and others), End-User (Hospitals, Rehabilitation Facilities, Academic Institutions and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 @ https://www.marketresearchfuture.com/reports/vein-illuminator-market-5735Regional analysis:North America led by the U.S. accounts for the largest market owing to faster adoption of technology, large buying power, developed healthcare infrastructure, presence of major players and others.Europe led by Germany, U.K. and France is expected to generate the second largest growth.However the market is expected to shift in favor of Asia Pacific region led by China, Japan and India.China has emerged as a low cost manufacturing base for electronic devices coupled with the development of global supply chains is boosting the market.The Middle East and Africa market is estimated to be skewed in favor of the Gulf nations such as Saudi Arabia, UAE and others.Africa is expected to generate moderate growth owing to poor economic and political conditions.Related NewsInfluenza Vaccination MarketMucormycosis MarketAbout Market Research Future:MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Epigenetics is the analysis and study of heritable changes in gene function not involving changes in the DNA sequence such as changes in a chromosome, phenotypic affecting gene activity, and expression.The global epigenetics market is valued at USD 800 million in 2016 and is expected to expand at a 12.9 % CAGR during the study period of 2016 to 2023.Market Dynamics:Oncology Segment Is Expected To Be The Largest Driver Of Market GrowthThe growing incidence of cancer is the prime drivers of the market.cancer was responsible for 8.8 million deaths in 2015, indenting nearly 1 in 6 patients deaths.Common carcinomas are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer, recording 1.69 million, 788,000, 774 thousand, 754 thousand, and 571 thousand deaths respectively in the year 2015.According to the estimates of the Centers for Disease Control and Prevention, almost 1.5 million people are diagnosed with cancer per year in the U.S. alone, resulting in more than five lakh deaths.Technology Development Is Expected To Drive A Faster Market AdoptionThe development of highly sensitive and selective tests, instrumentation and a concurrent rise in computational power is driving a broad adoption.The advancements such as the development of DNA and RNA modifying enzymes such as acetylases, methyltransferases, reverse transcriptase, ligases, and other protein-modifying enzymes has generated tremendous enthusiasm and concurrent faster market adoption.The growing government support for biotechnology and growing partnership between academia and industry is another driver of growth.Attractive and critical advantages of technology exemplified by high-throughput molecular analysis of tissues, such as quick, cost-effective, efficient for less labor intensive and requires a lesser number of steps are the operational and economic driving factors of the market.
Medical Marijuana Market 2018 Research Report implements an exhaustive study on Market Research Future.And also cover the other information such as Medical Marijuana Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023.Industry Synopsis:Global Medical Marijuana Industry is forecasted to expand remarkably at a CAGR of over 35.4% during the forecast period of 2018-2023.Medical marijuana or medical cannabis is the unprocessed marijuana plant or its extracts that are used to treat the symptoms of various diseases and other medical conditions.Marijuana consists of chemical components cannabinoids, which can be used as medicine to treat the symptoms caused by illness.Additionally, increasing U.S. Food and Drug Administration (FDA) approvals for drugs containing cannabinoids are contributing to the growth of the market.For instance, in June 2018, U.S. Food and Drug Administration (FDA) has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of epilepsy.The stringent regulatory environment for product approval, increasing use of marijuana for recreational use and side effects caused by long-term use of marijuana are likely to hinder market growth during the forecast period.Top Players:The key players profiled by MRFR that are operating in the global medical marijuana market are Canopy Growth, Aurora Cannabis, Inc., Cannabis Sativa, Inc, GW Pharmaceuticals plc, United Cannabis, MGC Pharma, Aphria, Inc., Tilray, Emerald Health Therapeutics [Canada] Inc., GBSciences, Inc., CanniMed Ltd., Medical Marijuana, Inc, Cara Therapeutics, and Greengro Technologies.Segmentation:The global medical marijuana market has been segmented on the basis of application, route of administration and distribution channel.On the basis of application, the market has been classified as Alzheimer’s disease, cancer, mental health conditions, multiple sclerosis, muscle spasms, glaucoma, and human immunodeficiency virus, acquired immunodeficiency syndrome (HIV/AIDS).Mental health conditions are differentiated into schizophrenia and posttraumatic stress disorder (PTSD).The route of administration segment has been further divided into oral, topical, inhalation and sublingual.
Insulin Delivery Devices Market Size, Application and Trends Analysis By Type (Insulin Syringes, Pen, Insulin Pumps, Insulin Jet Injectors, Pen Needles), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales And Diabetes Clinics/ Centers), End User and Region, Forecast Till 2025The Global Insulin Delivery Devices Market size is estimated to grow at a CAGR of 7.85% and expected to reach USD 21,804 Million by 2025, says Market Research Future (MRFR).Insulin delivery frameworks help in infusing insulin into the greasy tissue under the skin.Factors, such as developing diabetic populace, innovative headways in insulin delivery systems, and favoring repayment arrangements, expanding mindfulness among shoppers on the accessibility of a few delivery devices and advancement of human insulin devices are relied upon to positively affect the insulin delivery devices market.However, the accessibility of oral insulin as an elective medication delivery technique is probably going to hamper the development of the insulin delivery devices market.Expanding awareness about diabetic consideration is among the drivers for the insulin delivery devices market.Insulin delivery devices, including traditional syringes, without needle injectors, and auto and pen injectors, have been broadly used for the organization of insulin to treat type 1 diabetes issue.The worldwide market for insulin delivery devices has seen constantly expanding R Following the outlined course, it is anticipated that an expanding commonness of hyperglycemia, developing selection of self-injectable devices, and rising FDA endorsements drive the market development.
Market Research Future published a research report on Non-Invasive Prenatal Testing (NIPT) Market Research Report - Global Forecast till 2025.According to MRFR analysis, the global (NIPT) Market is expected to register a CAGR of 12.8% during the forecast period of 2019 to 2025 and was valued at USD 3,514.765 million in 2018.As a result of technological advancements, the global maternal mortality rate has reduced approximately less than 70 per 100,000 live births.The NIPT has benefited resolve issues related DNA deletion and other chromosomal disorders.The devices segment has been further classified as ultrasound devices, polymerase chain reaction instruments, microarrays, sequencing systems, and others.Consumables are further segmented into assay kits & reagents, disposables, and others.
Stem cells (SC) are a class of undifferentiated biological cells of a multicellular organism that have the ability to produce indefinite cells of the same type, from which certain types of cells (proliferation and replication) can be produced by differentiation in the body through early life and growth.The stem has the potential to develop into several different cell types, from muscle cells to brain cells.The government proposed investing 400 million yuan (around USD 56.4 million) to support stem cell research in China.SegmentationThe Global Stem Cell Banking Market has been segmented based on cell type, bank type, and application.Based on cell type, the market has been divided into umbilical cord stem cells, adult stem cells, and embryonic stem cells.On the basis of bank type, the global stem cell banking market has been classified into private banks, public banks, and hybrid banks.In addition, private banks have flexible collection sites and assured, and secured access offers a competitive advantage over public banks.
Industry Report “Lymphedema Treatment Market Research Report — Global Forecast till 2025” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement, macro economical and governing factors in the Lymphedema Treatment Market.Lymphedema Treatment Market is estimated to grow with a CAGR of 4.0%.Market SynopsisThe increasing prevalence of cancer is expected to drive the Global lymphedema treatment market by treatment.The strong clinical pipeline is likely to boost the market growth.Market players like HERANTIS PHARMA PLC, are developing curative treatment of secondary lymphedema — Lymfactin.Lymfactin is the world’s first and only clinical-stage gene therapy against lymphedema.The market potential of the drug is estimated to be around USD 650 Million.Market InfluencerIncreased research & development in the market is estimated to influence the commercialization in the market.The market is projected to witness a shift from symptomatic treatments to targeted treatment during the forecast period of 2018 to 2025.Key Players3A Health Care (Italy)Bio Compression Systems, Inc. (US)Devon Medical Products (US)HERANTIS PHARMA PLC (Finland)Lohmann & Rauscher (Germany)Mego Afek Ltd (US)SIGVARIS (Switzerland)Tactile Systems Technology Inc. (US)Wright Therapy Products (BSN Medical) (Germany)SegmentationBy TypePrimary Lymphedema is caused by the abnormal development of the lymph system.Symptoms may occur at birth or older age.
Behavioral Health Services Market Research Report - Global Forecast till 2025Behavior health services provide services to patients with mental health disorders, substance abuse disorders, and other mental disorders.Around 83% people in the US are suffering from behavioral health issues.According to Japanese study around 298 people were suffering from various behavioral disorders in 2018.According to MRFR analysis, behavioral health services market overview is expected to register a CAGR of 3.4% during the forecast period of 2019 to 2025 and was valued at USD 146.3 Billion by 2025.SegmentationThe Global Behavioral Health Services Market has been segmented based on services type, disorder type, and end user.The market, based on services type, has been divided into inpatient hospital treatment, outpatient counseling, home-based treatment services, emergency mental health services, and others.Around 1.3 million Americans are diagnosed with various behavioral disorders every year.Rising prevalence of anxiety disorder in most commonly seen in US.
Smart Inhalers Market Size, Growth and Trends Analysis By Type (Dry Powder Inhaler and Metered Dose Inhaler), Application (Asthma, Chronic Obstructive Pulmonary Disease and others), Key Players and Region (Americas, Europe, Asia-Pacific and Middle East and Africa), Forecast to 2025Smart Inhalers Market size and share is anticipated to reach USD 4.72 billion at a CAGR of 45% throughout the forecast period (2019-2025).Increasing population becoming susceptible to indoor air pollutants worldwide and Moreover, improved adherence rate driven by increasing patients preference to use digitalized medical devices for monitoring daily medication doses fosters the growth of the Smart Inhalers Market.Also, increased collaboration deeds between pharmaceutical companies and to promote technological advancements are contributing to market growth.Increased focus on advancement in treatment methods, R programs, online marketing strategies incorporated by key players in pharmaceutical and biotechnological industries are some of the major trends observed in the market.It is a new-age digital technology designed to empower patients, care contributors, researchers, and physicians related to respiratory diseases through objective and accurate medication monitoring and reminders.This makes smart inhalers the next big thing in the respiratory care segment.On the other hand, high costs associated with the smart inhalers and COPD & asthma treatments, limited availability of smart inhalers, and misinterpretation of information are some of the major factors obstructing the growth of the Smart Inhalers Market Companies.Wide range of benefits, including reducing financial costs associated with suboptimal medication adherence to enhanced efficacy of medicines, makes smart inhalers most preferred and popular in the respiratory care segment.leading players include AstraZeneca (UK), Adherium (New Zealand), Cohero Health (US), Gecko Health Innovations, Inc (US), GlaxoSmithKline (UK), Propeller Health (US), and Inspiro Medical (Israel), among others.Highly competitive by nature, the smart inhalers market appears to be fragmented due to the presence of market titans in the market.Key companies are venturing into new regions and countries with rapid expansion plans.
Market Research Future (MRFR) publishes periodic market research reports Nuclear Imaging Devices Market Research Report - Global Forecast till 2024 on niche and emerging technologies.The global nuclear imaging devices market is expected to grow significantly over the forecast period.It is anticipated that the market held a valuation of USD 2490 million in 2018 and is projected to register a CAGR of 5.2% over the forecast period.The increasing prevalence of cardiovascular disorders is one of the key factors driving the nuclear imaging devices market.As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease.SegmentationThe global Nuclear Imaging Devices Market size is segmented based on technology, application, end user, and region.The global market for nuclear imaging devices, by technology, is segmented into positron emission tomography (PET), single photon emission computed tomography (SPECT), and planar scintigraphy.The single-photon-emission computed tomography (SPECT) are further classified as hybrid SPECT systems and standalone SPECT systems.Based on application, the market is segmented into oncology, cardiology, neurology, and others.Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and others.The diagnostic imaging centers segment is expected to witness the fastest growth over the forecast period due to rising adoption of nuclear imaging in diagnostic centers.Intended AudienceMedical devices companiesGovernment and private laboratoriesResearch and development (R) companiesResearch laboratoriesMarket research and consulting service providersGlobal Nuclear Imaging Devices Market Research Report: Information by Technology (PET, SPECT (Hybrid SPECT Systems and Standalone SPECT Systems) and Planar Scintigraphy)), Application (Oncology, Cardiology, Neurology and others), End User (Hospitals, Diagnostic Imaging Centers and others) and Region - Global Forecast till 2024.For more info visit @https://www.marketresearchfuture.com/reports/nuclear-imaging-devices-market-8014Key PlayersSome of the key players in the global nuclear imaging devices market are Philips Healthcare, Digirad Corporation, Neusoft Medical Systems Co., Ltd., Progenics Pharmaceuticals Inc., Cannon Inc., Surgiceye GmbH, CMR Naviscan, Mediso Medical Imaging Systems Ltd., Agfa-Gevaert Group, General Electric Company, DDD-Diagnostic A/S, Spectrum Dynamics Medical, FMI Medical Systems, Inc., Segamicorp, and others.About Market Research Future:MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future published a research report on Cancer Registry Software Market Research Report — Global Forecast till 2024.Report gives a clear picture of current market scenario which includes past and estimated future market size.The global cancer registry software market is expected to grow significantly over the forecast period.The market held a market value of USD 56.4 million in 2018 and is projected to grow at a CAGR of 10.7% over the forecast period.Increasing prevalence of cancer, favorable government initiatives, rising pressure to improve the quality of care and reduce healthcare costs, rising adoption of EHRs, and the growing use of cancer patient registry data for post-marketing surveillance are positively affecting market growth.SegmentationBy type, the market has been segmented into integrated software and standalone software.Based on the deployment model, the market has been segmented into cloud-based models and on-premise models.On the basis of the database type, the market has been segmented into commercial databases and public databases.By functionality, the market has been segmented into patient care management, product outcome evaluation, cancer reporting to meet state and federal regulations, medical research & clinical studies.The cancer registry software market, by end-user, has been segmented into hospitals & medical practices, government organizations & research centers, pharmaceutical, biotechnology, and medical device companies, and others.Table of ContentChapter 6.Global Cancer Registry Software Market, By Type6.1 Introduction6.2 Integrated SoftwareMarket Estimates & Forecast, By Region, 2019–2024Market Estimates & Forecast, By Country, 2019–20246.3 Standalone SoftwareMarket Estimates & Forecast, By Region, 2019–2024Continued…Global Cancer Registry Software Market Research Report By Type, End User (Hospitals, Medical Practices, Government Organizations, Research Centers, Pharmaceutical, Biotechnology, Medical Device Companies and Others) — Forecast till 2024, For more info visithttps://www.marketresearchfuture.com/reports/cancer-registry-software-market-7852Intended Audience· Software companies· Contract research organizations· Academic and research institutes· Government associationsRelated NewsCraniomaxillofacial (CMF) Devices Market Research Report — Global Forecast till 2024Nuclear Imaging Devices Market Research Report — Global Forecast till 2024About Market Research Future:MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.Contact:https://www.marketresearchfuture.com
The Global Surgical Snare Market size is expected to grow at an approximate CAGR of 4.4% during the forecast period, 2018–2023.A surgical snare is a wire hoop use to tighten polyps or small tumors for severing, especially in body cavities.Surgical snares are extensively utilized in endoscopy.From the past few years, the market has grown with a rapid pace owing to the increasing number of endoscopy procedures, growing geriatric population, and rising healthcare expenditure.According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), about 30 to 40 percent of people in the United States get an H. pylori infection which is the cause of peptic ulcers.World Health Organization (WHO) estimates that based on a threshold of 4.4 skilled health professionals per 1000 population, the needs-based shortage of health-care workers globally would be about 17.4 million of which almost 2.6 million are doctors and over 9 million are nurses and midwives.SegmentationThe global surgical snare market is segmented based on usability, application, end user, and region.On the basis of usability, the global surgical snare market is segmented into reusable and single use.By application, the global surgical snare market by application is categorized into laparoscopy, endoscopy, cystoscopy, otoscopy, laryngoscopy, neuroendoscopy, and others.
Market Research Future (MRFR) publishes periodic market research report on Opioids Market Information: By Product (Extended-Release/Long-Acting Opioid, Immediate Release/Short Acting Opioid), by Application (Pain Relief, Anesthesia, Cough Suppression, Deaddiction, Others), by End User, and by Region — Global Forecast till 2023Leading Market PlayersSanofi SA (France), Pfizer Inc. (US), Boehringer Ingelheim GmbH (Germany), Teva Pharmaceutical Industries Ltd (Israel), Allergan Inc. (US), Purdue Pharma L.P. (US), West-Ward Pharmaceuticals Corporation (Jordan), Sun Pharmaceutical Industries Ltd (India), Egalet Corporation (US), Janssen Global Services, LLC (US), Vertice Pharma LLC (UK), Mallinckrodt (Surrey), and others.Opioids Market OverviewThe Opioids Market by types is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017.Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications.According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.Segmentation AnalysisThe global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids.The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others.The extended-release opioid segment accounted for a value of USD 12,750.91 million in 2017.The immediate-release opioid segment is further segmented into codeine, hydrocodone, fentanyl, morphine, and others.
Market HighlightsThe Global Surgical Retractors Market held a market value of USD 1,103 Million in 2017 and is projected to grow at a CAGR of 7.8% over the forecast period.Increasing number of surgical procedures leading to increase demand of surgical retractors.Surgical retractors are one of the important surgical instruments which is used to separate the edges of the wound or surgical incision.Due to increasing prevalence of obesity across the globe many of the companies are in the race to introduce better treatment for obesity.Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.Additionally, the growing research and development expenditure by the government as well as private sector is likely to contribute to the market growth.As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R) was Euro 33.1 billion (USD 35.2 billion) in the UK.However, the cost of surgery and surgical products may hamper the market growth during the assessment period.Regional AnalysisOn regional basis, the Americas is anticipated to dominate the global surgical retractors market owing to the growing R budgets by both government as well as commercial pharmaceutical and biotechnological companies and increasing adoption of advanced technologies in the region.Europe is expected to hold the second largest position in the global surgical retractors market owing to the presence of strong academic & research base and availability of funding for research in the European countries.Asia Pacific has served an opportunity for developing surgical retractors market in this region due to increasing demand for the better treatment and devices and increasing prevalence of disease like diabetes and obesity.The Middle East & Africa has the least share of the global surgical retractors market.
Epigenetics is the analysis and study of heritable changes in gene function not involving changes in the DNA sequence such as changes in a chromosome, phenotypic affecting gene activity, and expression.The global epigenetics market is valued at USD 800 million in 2016 and is expected to expand at a 12.9 % CAGR during the study period of 2016 to 2023.Market Dynamics: Oncology Segment Is Expected To Be The Largest Driver Of Market Growth The growing incidence of cancer is the prime drivers of the market.Common carcinomas are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer, recording 1.69 million, 788,000, 774 thousand, 754 thousand, and 571 thousand deaths respectively in the year 2015.Attractive and critical advantages of technology exemplified by high-throughput molecular analysis of tissues, such as quick, cost-effective, efficient for less labor intensive and requires a lesser number of steps are the operational and economic driving factors of the market.Other technological developments include automation, advances in PCR technology, strategic and cross-functional nature of the molecular diagnostic technology and others.High Cost Of Installation And Maintenance And Nascent Stage Of Technology May Hamper The Market Growth The prime market constraints include prohibitive costs of molecular diagnostics, the high cost of manufacturing, consolidated nature of the market has put a premium on the price of the epigenetics products, nascent stage of technology and high power of firms relative to buyers.
Global DNA sequencing market is expected to exhibit a strong 17.64% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR).The global DNA sequencing market is mainly driven by the growing prevalence of cancer and the growing awareness of the assistance DNA sequencing can provide in diagnosing it, the growing geriatric population and the growing prevalence of neurodegenerative conditions, and the growing awareness about DNA sequencing.Cancer is a major healthcare concern in modern times and has become a major disease to defeat for leading players in the global healthcare sector.Early diagnosis of cancer has been shown to be vital in beating the disease, with early diagnosis and screening significantly improving the chances of patients of beating the disease in the long run.DNA sequencing can be of help in this matter, as DNA sequencing allows patients to learn if they have a predetermined tendency to develop cancer.The growing burden of cancer on the global healthcare system is likely to be a major driver for the global illumina dna sequencing market The increasing prevalence of neurodegenerative diseases is also likely to be a major driver for the global DNA sequencing market over the forecast period.
Worldwide Blood Glucose Monitoring Market Research Report — Global Forecast till 2023 Size, Growth, Emerging Technologies, Demand, Competitive, Regional Landscape with Global Forecast To 2023Global continuous glucose monitoring market players is expected to grow at a CAGR of 7.1% during the forecast period 2017–2023.Leading Market PlayersSome of key the players in the market are Abbott Laboratories (U.S.), Arkay, Inc. (U.S.), Bayer Healthcare AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Goldsite Diagnostics Inc., GlySure Ltd (U.K), Sphere Medical Holding plc.The devices help to identify the blood glucose level within the specific target range.The surging prevalence of diabetes is likely to favour the market growth in the coming years.The blood glucose monitoring market is considered one of the rapidly expanding markets, mainly due to the surging growth in urbanization, leading to soaring incidences of obesity.The rising prevalence of type-II diabetes is fueling the growth of the use of blood glucose monitoring system.By mode of end-users, hospitals, diagnostic centers, research centers, clinics,and home care diagnostics.Among these, the homecare segment is considered to dominate the global market owing to an increased diabetic population coupled with the growing preference for minimally invasive technologies which can be used at home.Intended AudienceBlood Glucose Monitoring Devices SuppliersBlood Glucose Monitoring Devices ManufacturersResearch and Development (R) CompaniesMedical Research LaboratoriesAcademic Medical Institutes and UniversitiesHospitals and ClinicsHomecare DiagnosticsIndustry UpdatesJanuary 03, 2019: A team of researchers at KTH Royal Institute of Technology, Stockholm have recently developed a promising alternativefor people with diabetes.A microneedle patch with 50 times smaller than the needles used in the CGM systems, this glucose monitor is a reliable and comfortable blood-sugar monitoring system which has proven to be virtually painless and more accurate.Regional InsightsThe American region is estimated to command the largest market share and is likely to maintain its pole position in the coming years.
Laser Therapy Market Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) - Global Forecast from 2017 to 2023Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global Laser Therapy Devices Market over the forecast period of 2017-2023.YAG LASER, excimer LASER, femtosecond LASER, and others are the most commonly used lasers in ophthalmology.Expanding base of old population complements this factor since the elderly populace is more prone to acquiring diseases such as arthritis and cataract which induces additional demand for laser therapy.Heightened demand for minimally-invasive and non-invasive procedures is a major drive behind the growth of the market.Consumers are highly inclined towards medical procedures which do not involve incisions and cuts.A robust healthcare sector, high expenditure on healthcare, and widespread prevalence of chronic diseases in the region spur the growth of the global laser therapy market.In addition, the regions propensity to incorporate new and advanced technologies in the healthcare sector acts as a plus for the growth of the market.
The global Immunoassay Analyzers Market size is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities.On the other hand, high cost of instruments and poor reimbursement policies may restrain this growth during the forecasted period.SegmentationOn the basis of instruments :The market is classified into immunofluorescence, chemiluminescence, ELISA, enzyme linked fluorescent system, multiplexed assay system, radioimmunoassay and others.On the basis of application :The market is segmented into infectious diseases, autoimmune diseases, AIDS, endocrinology, drug monitoring, cardiology, oncology, allergy testing and others.On the basis of end users :The market is categorized into hospitals, diagnostic laboratories, research institutes, and others.Regional AnalysisThe global immunoassay analyzer market is dominated by America, which is followed by Europe.Presence of huge diabetic and cancer population, large geriatric population, and well developed healthcare sector has driven this market’s growth in America.Europe immunoassay analyzer market is majorly driven by the presence of large number of pharmaceutical and biotechnological companies.Along with these, Asia Pacific also has the fastest growing immunoassay analyzer market due to rapidly developing economies with huge population base, mainly in India and China.However, the Middle East & Africa has the least market due to limited development in the healthcare sector.Some of the major key player of this market areF.
Industry Report “Transplant Diagnostics Market Research Report – Global Forecast Till 2023” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement, macro economical and governing factors in the Digital Commerce Platform market.Transplant Diagnostics Market Research Report – Global Forecast Till 2023 to Reach USD 2,074.65 Million and driven by Increasing Numbers of Organ Transplant Procedures; Confirms MRFR OverviewThe global Transplant diagnostics Market is slated to display a CAGR of 7.80% from 2018 to 2023 (forecast period).It can touch a value of USD 2,074.65 million by 2023.Public-private partnerships are likely to expedite the rate of R due to subsidies and attractive incentives.Large number of transplantation procedures are likely to elicit the need for transplant diagnostic tests at clinics and hospitals.According to a collaboration between World Health Organization (WHO) and Organización Nacional de Trasplantes, 126,670 organs were transplanted in 2015.
Market Research Future published a study report on Global Ischemic strokes Market.Ischemic strokes Market research report categorizes the market by companies, region, type and end-use industry.Market Scenario:Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain.The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.As per the Centers for Disease Control and Prevention (CDC), stroke leads to 1 out of every 20 deaths costing around USD 34 billion each year in the U.S. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.The key strategies adopted by leading industry players incldues new product launches and collaborations.This minimally invasive technique is designed to access the common carotid artery.Moreover, in March, 2015, WATCHMAN, a closure device designed to prevent stroke in patients with atrial fibrillation received FDA approval.Rising cases of ischemia stroke are driving the demand for surgical procedures in stroke treatment.
Narcolepsy is a medical condition which is characterized by overwhelming daytime drowsiness and sudden attacks of sleep.Sometimes, this chronic sleep disorder can lead to a sudden loss of muscle tone (cataplexy), leading to weakness and loss of muscle control.Sleep paralysis, hallucinations, daytime sleepiness, fragmented sleep & insomnia, besides others are some of the most common symptoms of the disease.Increasing prevalence of narcolepsy, growing the obese population, increasing demands for effective treatment, rising research and development are estimated to be some of the significant drivers for the Global narcolepsy market.However, lack of awareness and low per capita healthcare expenditure in the middle and low-income countries may restraint the Global narcolepsy market growth, during the forecast period.Global Narcolepsy Market is expected to grow at an approximate CAGR of 8.2% during the forecast period.Global Narcolepsy Market Share report gives expected growth of Top players at CAGR 8.2% during the forecast period of 2018-2023.Market is segmented on the basis of type, diagnosis, treatment, and end user.Key Players for Global Narcolepsy MarketJazz Pharmaceuticals plc (Republic of Ireland), BIOPROJET (Paris), Arena Pharmaceuticals, Inc. (U.S.), Graymark Healthcare, Inc. (U.S.), Mylan N.V. (U.S., Teva Pharmaceutical Industries Ltd. (Israel), Novartis AG (Switzerland), Shire (Republic of Ireland), Shionogi Inc. (U.S.), Ligand Pharmaceuticals, Inc. (U.S.), and othersRegional Analysis for Global Narcolepsy MarketAmerica dominates the Global narcolepsy market owing to a well-developed healthcare sector, high healthcare expenditure and a huge patient population.
Global Patient Blood Management Market Research Report: By Product (Instruments, Accessories, Reagents and Kits, Software), By Component (Whole Blood, Plasma) and By End-User (Blood Banks, Hospitals, Diagnostic Clinics and & Pathology Labs) – Forecast to 2025Download Sample (112 Pages PDF) Report For Free: To Know the Impact of COVID-19 on this Industry @ https://www.marketresearchfuture.com/sample_request/8798Patient Blood Management Market Analysis The global patient blood management market is likely to touch USD 15,848 million at a 6.48% CAGR between 2019- 2025, as per the recent report by Market Research Future (MRFR).Patient blood management is used for minimizing blood loss at the time of surgical operations and optimizing the blood of the patient.This is carried out by doctors for patients that possess the risk of blood loss at the time of surgical intervention.Some of its different types include software, reagents and kits, and instrument accessories.Patient Blood Management Market Studied by Key PlayersLeading players profiled in the patient blood management market report include Immucor, Inc., Grifols, S.A, Terumo Corporation, Hitachi, Ltd., Danaher Corporation, Abbott Laboratories, B. Braun Melsungen AG, Fresenius Se & Co. KGaA, Bio-Rad Laboratories, Inc., and Biomérieux SA.Industry players have encompassed several strategies to create a niche in the market and also cater to the burgeoning needs of customers.These comprise yet is not limited to geographic expansions, joint ventures and collaborations, partnerships, strategic alliances, contracts, mergers and acquisitions, new product launches and development, extensive research and development activities, and more.Patient Blood Management Market SegmentationThe MRFR report offers an inclusive segmental analysis of the global patient blood management market report based on end user, component, and product.By product, the global patient blood management market is segmented into software, reagents and kits, and instrument accessories.
Global Carrier Screening Market Research Report, by Product & Service (Services and Products), Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Medical Condition (Pulmonary Conditions, Hematological Conditions, Neurological Conditions, and others), Technology (Polymerase Chain Reaction and Microarrays), End-User (Hospitals, Reference Laboratories, Physician Offices, and Clinics and others) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) – Forecast till 2025Free Sample Copy of Carrier Screening Market With Considering Coivd19 Impact on this Market : https://www.marketresearchfuture.com/sample_request/8755Various factors are adding to the global carrier screening market growth.As per the latest MRFR report, these factors comprise growing awareness about carrier screening, technological advances, growing emphasis on early detection & prevention, increasing number of players involved new carrier screening technology development, and new product launch.Carrier Screening Market Regional Analysis Based on the region, the global carrier screening market report covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), & the Middle East and Africa.Of these, the Americas will have the lions share in the market over the forecast period.Increasing awareness about genetic disorders & its diagnosis methods, and the huge patient population suffering from genetic diseases are adding to the global carrier screening market growth in the region.The global carrier screening market in Europe is predicted to hold the second-largest share over the forecast period.The presence of several healthcare companies, rising focus on personalized medicine, and increasing R activities are adding to the global carrier screening market growth in the region.The global carrier screening market in the APAC region is predicted to grow at a fast pace over the forecast period.Increasing awareness regarding the diagnosis techniques of genetic disorder coupled with increasing market growth is adding to the global carrier screening market growth in the region.The global carrier screening market in the MEA is predicted to have the smallest share over the forecast period for a low per capita disposable income, especially in Africa’s underdeveloped regions, lack of awareness regarding the disease condition, and limited healthcare infrastructure.Carrier Screening Market Key PlayersLeading players profiled in the global carrier screening market report include Laboratory Corporation of America Holdings (US), Natera Inc (US), Luminex Corporation (US), Thermo Fisher Scientific Inc (US), Illumina Inc (US), Myriad Genetics (US), Sema4 (US), Quest Diagnostics Incorporated (US), Fulgent Genetics Inc (US), Opko Health (US), Invitae Corporation (US), and Eurofins Scientific (Luxembourg).
Global Angioplasty Balloons Market: By Product Type (Normal Balloons, Cutting Balloons, Drug Eluting Balloons, Scoring Balloons), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Others) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) – Forecast to 2027Free Sample Copy of Angioplasty Balloons Market With Considering Coivd19 Impact on this Market: https://www.marketresearchfuture.com/sample_request/9614Market HighlightsAccording to MRFR analysis, the Global Angioplasty Balloons Market is expected to register a CAGR of 5.01% from 2020 to 2027 and hold a value of USD 3457.35 Million till 2027.The Global Angioplasty Balloons Market is driven by several factors, such as technological advancements in balloons, increasing preference for minimally invasive procedures, surging prevalence of cardiac diseases, rising initiatives by public and private organizations to create awareness regarding angioplasty treatment options, increasing product launches and a number of clinical trials by the prominent players in the market.For instance, the European Atherosclerosis Society (EAS) creates awareness related to new developments and innovations to prevent atherosclerosis.Competition OutlookSome of the key players in the global angioplasty balloons market are B. Braun Melsungen AG (Germany), Abbott (US), Biotronik SE & Co. KG (Germany), C.R.Bard (BD) (US), Boston Scientific Corporation (US), Cook (US), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), Terumo Medical Corporation (Japan), Cordis (Cardinal Health) (US), and Endocor (Germany).SegmentationThe global angioplasty balloons market has been segmented based on product type, application, and end user.The market, based on product type, has been segmented into normal balloons, cutting balloons, drug eluting balloons, and scoring balloons.The market, based on normal balloons, held a major share in 2018 owing to the widespread use and high preference rate.The drug eluting balloons segment is expected to be the fastest-growing segment during the forecast period due to the continued innovations by players.The market, based on application, has been segmented into coronary artery disease and peripheral artery disease.The coronary artery disease segment held the largest share in 2019 owing to the increased cardiac cases across the globe, whereas the peripheral artery segment is anticipated to be the fastest-growing segment due to the increasing strategic initiatives by key players in this segment by prominent players.The global angioplasty balloons market has been segmented, based on end user, into hospitals, cardiac catheterization laboratories, ambulatory surgical centers, and others.
Global Dry Mouth Relief Market: Information by Type (Spray, Mouthwash, Gel, Lozenges), Distribution Channel (Pharmacies, E-Commerce, Supermarket) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) – Forecast till 2026Market HighlightsDry Mouth Relief Marketis expected to register a CAGR of 4.10% during the forecast period, with a market value of USD 2,777.14 Million by 2026.Dry mouth, also known as xerostomia, occurs because of the lack of saliva production.Typically, dry mouth is not a disease but is a result of various conditions such as side-effects of certain medicines, cigarette smoking, harmful effects of radiation exposure to the areas of head and neck, dehydration, aging population, and mouth bleeding, among others.Segment AnalysisGlobal Dry Mouth Relief Market has been segmented by Type and Distribution Channel.The market, based on type, has been bifurcated into spray, mouthwash, gel, lozenges, and others.get free sample copy @ https://www.marketresearchfuture.com/sample_request/9581Key Findings of the StudyThe Global Dry Mouth Relief Market is estimated to reach USD 2,777.14 Million by 2026 at a CAGR of 4.10% during the assessment periodThe Americas accounted for the largest share of the global dry mouth relief market due to the rising prevalence of xerostomiaBased on type, the spray segment is expected to account for the largest market share of 39.9% by 2026On the basis of distribution channel, the pharmacies segment is expected to account for the largest market share of 57.0% by 2026Regional AnalysisThe global dry mouth relief market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.The Americas is likely to dominate the global dry mouth relief market.This can be attributed to the rising patient population suffering from dry mouth or xerostomia in the region.According to the American Dental Association in July 2019, the prevalence of xerostomia ranges from 0.9% to 64.8%.
Global Medical Gloves Market: By Product Type (Examination, Surgical, Chemotherapy), By Usage (Disposable, Reusable), By Form (Powdered, Non-powdered), By Raw Material (Latex, Nitrile rubber, Vinyl rubber, Neoprene, Polyethylene) and By End-User (Hospitals and Clinics, Ambulatory surgery centers, Diagnostic centers, Rehabilitation centers) – Forecast till 2027Medical gloves are used personal protective equipment during medical examinations or surgical procedures.The global medical gloves market report by Market Research Future (MRFR) takes a look at the improvements in such gears and its response to the COVID-19 pandemic.The report contains drivers, challenges, trends, opportunities, and threats for the period of 2020 to 2027 (forecast period).Free Sample Copy of Medical Gloves Market With Considering Coivd19 Impact on this Market @https://www.marketresearchfuture.com/sample_request/9707Medical Gloves Market ScopeThe global medical gloves market size was estimated at USD 8,638.19 million in 2019 and is expected to reach USD 17,399.81 million by the end of 2027.It is predicted to grow at a CAGR of 8.73% over the forecast period.It can face a huge demand during the forecast period owing to the outbreak of the COVID-19 pandemic.The surge in number of surgeries and the large geriatric populace being admitted in emergency wards can warrant the use of medical gloves.However, defective gloves, low production capacity due to its toxic reaction among certain sections of the populace, and risk of reusable gloves can act as deterrents for the market.Medical Gloves Market SegmentationThe global medical gloves market is segmented by product type, usage, raw material, form, and end user.By product type, it is segmented into chemotherapy, surgical, and examination.Surgical gloves are expected to control a major share of the market.
Market PlayersHoffmann-La Roche Ltd (Switzerland), BMS (U.S), Merck & Co., Inc (U.S), Vertex Pharmaceuticals Incorporated (U.S), Gilead sciences Inc (U.S.)., Abbvie Inc (U.S.), Johnson & Johnson (U.S.), Glaxosmithkline plc (U.K), Novartis AG (Switzerland), Bristol-Myers Squibb (U.S.) are some of the prominent players at the forefront of competition in the Global HHepatitis C Treatment Marketis the inflammation of liver caused by infection by hepatitis C virus characterized by a host of symptoms such as yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay coloured stools etc.According to the World Health Organisation, hepatitis C affects between 130–150 million people globally every year claiming a toll of 700000 lives.Of those who recover about 15-20% develop liver cirrhosis or liver cancer.epatitis C Diagnosis and Treatment Market and are profiled in MRFR Analysis.According to Centres for Disease Control & Prevention, in U.S., liver cancer incidence is increasing at a rapid rate (2.3 % per year overall from 2003 – 2012), second only to thyroid cancer.On the other hand, the market constraining factors are self-imitating nature of the disease in a sizable number of patients, challenge of herbal treatment offered at negligible prices especially in developing regions, price war between companies such as between Gilead and Merck, rising urbanization and better sanitation etc.Global Hepatitis C Diagnosis and Treatment Market-Competitive AnalysisOctober, 2013 - Janssen (Parent organisation Johnson & Johnson Services, Inc.) acquired investigational NS5A Inhibitor for the treatment of Hepatitis C from GlaxoSmithKline.According to company reports, GSK2336805 is an investigational NS5a replication complex inhibitor in Phase 2 development for the treatment of chronic hepatitis C in adult patients with compensated liver disease, including all stages of liver fibrosis.October, 2013 - Bristol-Myers Squibb to presented range of new Hepatitis C data at the 2013 American Association for the Study of Liver Diseases (AASLD).Moreover, company stated NS5A replication complex inhibitor daclatasvir (DCV) had been extensively studied in thousands of patients to date as a foundational agent for multiple DAA-based combination therapies and is currently in Phase III development.DCV has shown antiviral potency and pan-genotypic activity across HCV genotypes in vitro.
The rising prevalence of angina and coronary heart diseases, growing healthcare expenditure, and increasing geriatric and obese population are expected to drive the global angina market, during the forecast period.However, low per capita healthcare expenditure and high cost for therapeutic procedures such as coronary bypass surgery restraints the market growth.Angina Market is expected to grow at an approximate CAGR of 5.1% during the forecast periodThe Market Key Players are:· Anthera (U.S.),· Taxus Cardium (U.S.),· Astellas Pharma (Japan),· Sanofi (France),· Bayer AG (Germany),· Merck & Co., Inc. (U.S.),· Torrent Pharmaceuticals Limited (India),· Huya Bioscience International (U.S.),· Viromed Co. Ltd. (South Korea),· Baxter (U.S.),SegmentationThe global angina market is segmented on the basis of type, diagnosis, treatment, and end-user.· On the basis of type, the market is segmented into angina pectoris, unstable angina, prinzmetal angina, and others.· On the basis of diagnosis, the market is categorized into imaging, blood test, stress test, and others.The blood test segment is sub-segmented into cholesterol test, low-density lipoprotein test, triglycerides test, and others.· On the basis of treatment, the market is segmented into lifestyle changes, medications, angioplasty and stenting, coronary bypass surgery, and others.The medication segment is sub-segmented into aspirin, clot-preventing drugs, statins, ranolazine, and others.The clot-preventing drugs segment is further segmented into clopidogrel, prasugrel, and others.· On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, academic institutes, and othersGlobal Angina Market Research Report, by Type (Angina Pectoris), Diagnosis (Imaging, Stress Test), Treatment (Lifestyle, Medications, Angioplasty, and Stenting), End-Users (Hospital & Clinics, Diagnostic Centers, Academic Institutes)–Forecast Till 2023 @ https://www.marketresearchfuture.com/reports/angina-market-5748Regional AnalysisAmerica dominates the global angina market.This can be attributed to the presence of a well-developed healthcare sector and a huge patient population for coronary heart diseases.
The growth of the global somatostatin analogs market is driven by various factors such as increasing research & development activity in the somatostatin analogs market and increasing numbers of players involved in the development of generic versions of somatostatin analogs.In addition, the rising incidence rate of the NETs; and increasing efforts by government bodies and public and private organizations to increase awareness about Acromegaly are some of the other factors for the growth of the somatostatin analogs market.However, lack of awareness leading to a high number of undiagnosed people, and the availability of the alternative treatment options for the treatment of NETs and Acromegaly are thwarting the growth of the somatostatin analogs market.Thus, there is a change in the competitive scenario in the somatostatin analogs market.The increasing number of companies bring more investments in the market which positively impacts the growth of the market.The presence of a number of product manufacturers such as Novartis AG (Switzerland), Ipsen Pharma (France), Fresenius Kabi (Germany) is one of the factors pushing the growth of the regional market.